Literature DB >> 8367221

Chronic modifications of lung and heart development in glucocorticoid-treated newborn rats exposed to hyperoxia or room air.

D W Thibeault1, B Heimes, M Rezaiekhaligh, S Mabry.   

Abstract

We assessed the mechanics and morphology of the lung in 165 rats treated neonatally with either room air (RA), O2, RA + steroids, or O2 + steroids. Newborn Sprague-Dawley male rats were randomly assigned to these groups. O2-exposure (0.96-1.0 FiO2) lasted 5 days, and dexamethasone treatment consisted of eight daily S.C. injections of drug or buffer in successive doses of 0.5, 0.4, 0.3, 0.2, 0.1, 0.1, 0.1, and 0.1 mg/kg. At 58 days, right ventricular systolic pressure (RVP) was measured. At 60 days, all rats were sacrificed for obtaining lung weight and DNA, saline pressure-volume (P-V) curves, and morphometry. We weighted right ventricles (RV) and left ventricles + septa (LV). Hyperoxia alone did not, but steroid decreased survival rate to 79.4% (95.3% in RA rats, P < 0.02). Only 21 of 40 (52%) O2 + steroids rats survived, less than in both RA groups (P < 0.001). RV weight, RVP and muscularization of alveolar duct arteries were significantly increased in O2 vs. RA rats. In RA + steroids rats, weight of the LV was decreased but RV, RVP, and lung vasculature were not affected. These effects were additive in the O2 + steroid group. Wet lung weights and DNA were increased for RA + steroid rats over all others. O2 and steroids shifted the P-V curve to the left and O2 + steroids still further. Maximal lung volume increased significantly with RA + steroids and still further in O2 + steroids but not in O2 alone. O2 and steroids significantly increased the mean linear intercept and O2 + steroids even more so.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8367221     DOI: 10.1002/ppul.1950160202

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  5 in total

1.  Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats.

Authors:  Emilio A Herrera; Misha M Verkerk; Jan B Derks; Dino A Giussani
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

Review 2.  HRCT in paediatric diffuse interstitial lung disease--a review for 2009.

Authors:  Maria Klusmann; Catherine Owens
Journal:  Pediatr Radiol       Date:  2009-06

3.  Oxidative stress in the developing brain: effects of postnatal glucocorticoid therapy and antioxidants in the rat.

Authors:  Emily J Camm; Deodata Tijsseling; Hans G Richter; Alexandra Adler; Jeremy A Hansell; Jan B Derks; Christine M Cross; Dino A Giussani
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

4.  Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy.

Authors:  Youguo Niu; Emilio A Herrera; Rhys D Evans; Dino A Giussani
Journal:  J Physiol       Date:  2013-08-12       Impact factor: 5.182

5.  The radiology of diffuse interstitial pulmonary disease in children: pearls, pitfalls and new kids on the block in 2015.

Authors:  Thomas Semple; Catherine M Owens
Journal:  Radiol Med       Date:  2015-11-20       Impact factor: 6.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.